Tolazamide - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for tolazamide and what is the scope of patent protection?
Tolazamide
is the generic ingredient in two branded drugs marketed by Barr, Chartwell Rx, Cosette, Duramed Pharms Barr, Interpharm, Mylan Pharms Inc, Par Pharm, Sun Pharm Industries, Superpharm, Usl Pharma, Watson Labs, and Pharmacia And Upjohn, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.There are six drug master file entries for tolazamide.
Summary for tolazamide
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 12 |
NDAs: | 31 |
Drug Master File Entries: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Clinical Trials: | 3 |
Patent Applications: | 6,649 |
Formulation / Manufacturing: | see details |
DailyMed Link: | tolazamide at DailyMed |
Recent Clinical Trials for tolazamide
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Canadian Network for Observational Drug Effect Studies, CNODES | |
Drug Safety and Effectiveness Network, Canada | |
Canadian Institutes of Health Research (CIHR) |